Literature DB >> 22236445

Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children.

Junhong Ai1, Zhengde Xie, Chunyan Liu, Zhizuo Huang, Junmei Xu.   

Abstract

BACKGROUND: In China, primary EBV infection occurs during childhood with seroprevalence reaching about 100% by 10 years of age. There are few studies on EBV variants in diseases associated with EBV infection in Chinese children. In this study, we investigated the diversity of the EBV genes (EBNA-1 and LMP-1) and the relationship between EBV variants and the clinical phenotypes in diseases associated with EBV infections in Chinese pediatric cases.
RESULTS: The frequencies of EBV type I in the IM, HLH and HL samples were 98.4%, 100% and 95.8%, respectively. Three known EBNA-1 variants were identified, including V-val (all were V-val-v1 sub-variant), P-thr' and V-Leu (MT). The frequency of V-val-v1 was 98.6% in the IM samples, 100% in the HLH samples and 97.1% in the HL samples. There were no significant differences of the distribution of EBNA-1 variants between IM, HLH and HL samples (P > 0.05). Three known LMP-1 variants, including China 1, China 2 and Med, were identified and China 1 was predominant in all groups (IM 88.6%, HLH 100% and HL 100%). The frequency of del-LMP-1 was 88.6% in the IM samples, 100% in the HLH samples and 96.0% in the HL samples. There were no significant differences in the frequency of del-LMP-1 between the IM, HLH and HL samples (P > 0.05). The frequency of XhoI loss was 90.6% in the IM samples, 100% in the HLH samples and 100% in the HL samples, with no significant difference in frequency (P > 0.05). In the EBV type I strain, V-val-v1 variant (EBNA-1) was linked with China1 variant (LMP-1) in 88.9% of the IM samples, 100% of the HLH samples and 80.0% of the HL samples in this study.
CONCLUSIONS: Type I EBV was the most prevalent subtype EBV in Chinese pediatric cases and V-val-v1 (EBNA-1) and China1 (LMP-1) variants were the most dominant variants. There was a strong linkage between V-val-v1 (EBNA-1) variant and China1 (LMP-1) variant in type I EBV. The sequence variation in EBV genes may represent a geographic polymorphism since no preferential associations were found between specific EBV variants and specific diseases in this study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236445      PMCID: PMC3269356          DOI: 10.1186/1743-422X-9-13

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  40 in total

1.  Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.

Authors:  Boutheina Hadhri-Guiga; Abdel-Majid Khabir; Raja Mokdad-Gargouri; Abdel-Monem Ghorbel; Mohamed Drira; Jamel Daoud; Mounir Frikha; Rachid Jlidi; Ali Gargouri
Journal:  Virus Res       Date:  2005-09-08       Impact factor: 3.303

2.  Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.

Authors:  Vannarat Saechan; Atsumi Mori; Winyou Mitarnun; Wannapa Settheetham-Ishida; Takafumi Ishida
Journal:  J Clin Virol       Date:  2006-04-17       Impact factor: 3.168

3.  Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line.

Authors:  Shi-Juan Mai; Tadamasa Ooka; Da-Jiang Li; Mu-Sheng Zeng; Ri-Cheng Jiang; Xing-Juan Yu; Ru-Hua Zhang; Shi-Ping Chen; Yi-Xin Zeng
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

4.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

5.  Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma.

Authors:  Masayoshi Nagamine; Miki Takahara; Kan Kishibe; Toshihiro Nagato; Hideyuki Ishii; Nobuyuki Bandoh; Takeshi Ogino; Yasuaki Harabuchi
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

6.  A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8.

Authors:  Nguyen-Van Do; Ernberg Ingemar; Phan-Thi Phi Phi; Almqvist Jenny; Tran-Thi Chinh; Yixin Zeng; Lifu Hu
Journal:  Virus Res       Date:  2007-12-21       Impact factor: 3.303

7.  [Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma].

Authors:  Su-xia Lin; Yong-sheng Zong; Min Zhang; An-jia Han; Bi-ling Zhong; Ying-jie Liang
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2005-12

8.  Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.

Authors:  Deisy M Guiretti; Paola A Chabay; Pamela Valva; Claudio G Stefanoff; Mário H M Barros; Elena De Matteo; Ilana Zalcberg Renault; Maria Victoria Preciado; Rocio Hassan
Journal:  J Med Virol       Date:  2007-11       Impact factor: 2.327

9.  The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.

Authors:  A Aiyar; C Tyree; B Sugden
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

10.  Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.

Authors:  Y Y Chen; K L Chang; W G Chen; D Shibata; K Hayashi; L M Weiss
Journal:  Lab Invest       Date:  1998-07       Impact factor: 5.662

View more
  11 in total

1.  As Evidence-Based Tumorigenic Role of Epstein-Barr Virus miR-BART1-3p in Neurological Tumors.

Authors:  Mohammad Karimzadeh; Alireza Tabibzadeh; Mohsen Moghoofei; Saeedeh Abbasi; Javid Sadri Nahand; Farzin Sadeghii; Mohammad Hadi Karbalaie Niya; Hossin Keyvani; Farah Bokharaei-Salim; Moein Esghaei; Maryam Esghaei
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

2.  Molecular Investigation of Human Cytomegalovirus and Epstein-Barr virus in Glioblastoma Brain Tumor: A Case-Control Study in Iran

Authors:  Hadi Ghaffari; Ahmad Tavakoli; Mohammad Faranoush; Ali Naderi; Seyed Jalal Kiani; Alireza Sadeghipour; Davod Javanmard; Mohammad Farahmand; Saied Ghorbani; Farnoush Sedaghati; Seyed Hamidreza Monavari
Journal:  Iran Biomed J       Date:  2021-11-01

Review 3.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08

4.  Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China.

Authors:  Lingling Sun; Zhenzhen Zhao; Song Liu; Xia Liu; Zhifu Sun; Bing Luo
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

5.  Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer.

Authors:  Sylwia Fołtyn; Małgorzata Strycharz-Dudziak; Bartłomiej Drop; Anastazja Boguszewska; Małgorzata Polz-Dacewicz
Journal:  Infect Agent Cancer       Date:  2017-05-30       Impact factor: 2.965

6.  Analysis of the Variability of Epstein-Barr Virus Genes in Infectious Mononucleosis: Investigation of the Potential Correlation with Biochemical Parameters of Hepatic Involvement.

Authors:  Ana Banko; Ivana Lazarevic; Goran Stevanovic; Andja Cirkovic; Danijela Karalic; Maja Cupic; Bojan Banko; Jovica Milovanovic; Tanja Jovanovic
Journal:  J Med Biochem       Date:  2016-07-06       Impact factor: 3.402

7.  A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.

Authors:  Magdalena Gantuz; Mario Alejandro Lorenzetti; Paola Andrea Chabay; María Victoria Preciado
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

8.  Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia.

Authors:  Doris Kafita; Trevor Kaile; Evans Malyangu; Rabecca Tembo; Ephraim Zulu; Chrispin Chisanga; Annie Kalonda; Mulemba Samutela; Pascal Polepole; Geoffrey Kwenda
Journal:  Pan Afr Med J       Date:  2018-03-28

9.  Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.

Authors:  Ana V Banko; Ivana B Lazarevic; Miljan M Folic; Vojko B Djukic; Andja M Cirkovic; Danijela Z Karalic; Maja D Cupic; Tanja P Jovanovic
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

Review 10.  EBV and the Pathogenesis of NK/T Cell Lymphoma.

Authors:  Ivonne A Montes-Mojarro; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.